Information  X 
Enter a valid email address

Avacta Group PLC Ord 10P (AVCT)

Date Time Source Announcement
23 Apr 2019 3:48 pm
RNS
Issue of Equity
12 Apr 2019 2:46 pm
RNS
Holding(s) in Company
09 Apr 2019 7:00 am
RNS
Interim Results
08 Mar 2019 12:14 pm
RNS
Issue of Equity
06 Feb 2019 12:27 pm
EQS
Avacta (AVCT): A second wake-up call for the market
04 Feb 2019 7:00 am
RNS
Moderna Exercises Exclusive Product License Option
28 Jan 2019 7:00 am
RNS
Director Appointment
21 Jan 2019 3:40 pm
RNS
Result of Annual General Meeting
  7:00 am
RNS
AGM Business Update and Notice of Results
18 Jan 2019 5:08 pm
RNS
Share Incentive Plan/Issue of Equity
  10:00 am
RNS
Change of accounting reference date
09 Jan 2019 11:06 am
RNS
Holding(s) in Company
  11:06 am
RNS
Holding(s) in Company
07 Jan 2019 2:50 pm
RNS
Director/PDMR Shareholdings
03 Jan 2019 8:56 am
RNS
Holding(s) in Company
  8:56 am
RNS
Holding(s) in Company
02 Jan 2019 7:00 am
RNS
Director/PDMR Shareholding
21 Dec 2018 1:41 pm
RNS
Holding(s) in Company
19 Dec 2018 3:32 pm
RNS
Holding(s) in Company
17 Dec 2018 7:00 am
RNS
Avacta London Science Day
12 Dec 2018 12:50 pm
RNS
Holding(s) in Company
  12:44 pm
RNS
Holding(s) in Company
  12:44 pm
RNS
Holding(s) in Company
  7:00 am
RNS
Appointment of Chief Medical Officer
11 Dec 2018 7:00 am
RNS
Posting of Annual Report and Notice of AGM
10 Dec 2018 2:05 pm
RNS
Second Price Monitoring Extn
  2:00 pm
RNS
Price Monitoring Extension
  7:30 am
EQS
Avacta (AVCT): Wake-up call for the market
  7:00 am
RNS
Development Partnership with LG Chem Life Sciences
12 Nov 2018 7:00 am
RNS
Avacta to Present at Major European Conference
11 Oct 2018 7:00 am
RNS
Avacta's CTO to Present at Major US Conference
10 Oct 2018 7:00 am
RNS
Avacta agrees Affimer reagent licensing deal
02 Oct 2018 7:00 am
RNS
Preliminary Results
21 Sep 2018 7:00 am
RNS
Investor Meeting and Presentation
05 Sep 2018 7:15 am
EQS
Avacta (AVCT): Capital increase for further development
  7:00 am
RNS
Notice of Results
31 Aug 2018 9:55 am
RNS
Holding(s) in Company
  9:55 am
RNS
Holding(s) in Company
23 Aug 2018 5:07 pm
RNS
Holding(s) in Company
  5:06 pm
RNS
Holding(s) in Company
  11:21 am
RNS
Holding(s) in Company
22 Aug 2018 2:23 pm
RNS
Holding(s) in Company
  9:20 am
RNS
Holding(s) in Company
17 Aug 2018 11:30 am
RNS
Result of General Meeting
06 Aug 2018 4:24 pm
RNS
Holding(s) in Company
  4:24 pm
RNS
Holding(s) in Company
30 Jul 2018 6:06 pm
RNS
Results of Placing and Subscription
  11:41 am
RNS
Proposed Placing and Subscription to raise �11.4m
  10:35 am
EQS
Avacta (AVCT): Ground-breaking new drug conjugate platform
24 Jul 2018 7:00 am
RNS
Major Therapeutics Co-development Partnership
26 Jun 2018 1:30 pm
EQS
Avacta (AVCT): Gearing up the management team
11 Jun 2018 7:00 am
RNS
Appointment of Non-Executive Chairman
31 May 2018 12:15 pm
EQS
Avacta (AVCT): In vivo expression of Affimers
22 May 2018 7:00 am
RNS
Successful Outcome of Study with FIT Biotech
30 Apr 2018 4:45 pm
RNS
Holding(s) in Company
17 Apr 2018 7:15 am
EQS
Avacta (AVCT): Commendable rate of progress
16 Apr 2018 7:25 am
RNS
Interim Results
09 Apr 2018 2:58 pm
RNS
Issue of Equity
29 Mar 2018 7:00 am
RNS
Avacta to Present at Investor Forum
  7:00 am
RNS
Directorate Change
 
Headlines
Top categories
Company finder

a d v e r t i s e m e n t